CAMBRIDGE, Mass., Nov. 11 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals
Incorporated (Nasdaq: VRTX) will webcast its corporate presentation at Credit
Suisse First Boston's Health Care Conference in Phoenix, Arizona. Ian Smith,
Vertex's Senior Vice President and Chief Financial Officer, will deliver the
presentation on Wednesday, November 16, 2005 at 8:30 a.m. MST (10:30 a.m.
EST).
The presentation will be webcast live and may be accessed by visiting the
Vertex website at http://www.vrtx.com. A replay of the webcast will also be
available on the Company's website until November 30, 2005. To access the
webcast, go to Vertex's website and select the '2005 Credit Suisse First
Boston's Health Care Conference' from the 'Events Calendar.' To ensure a
timely connection to the webcast, it is recommended that users register at
least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral
diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes
the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
Company News On-Call:
http://www.prnewswire.com/comp/938395.html
CONTACT:
Lora Pike, Manager, Investor Relations at
Vertex Pharmaceuticals Incorporated, +1-617-444-6755
|
